Elevated expression level of AIM2 in senescent prostate epithelial cells is associated with increased IL-1β production and development of benign prostatic hyperplasia, whereas the expression of AIM2 in prostate cancer cells is low [26]. This evidence concerns the gene AIM2 and prostate carcinoma.